semaglutide malta Oral Gets FDA Approval for CV Event Reduction in High-risk Diabetes Patients Trying to manage weight? Rybelsus®

While its efficacy in managing blood sugar levels and promoting weight loss is well-documented, recent reports have raised concerns about potential side effects associated with its use

No portal jail, no hold music. Tom H

Asia-Pacific is the fastest-growing regional GLP-1 drug market at 22.6% CAGR , driven by rapidly rising obesity prevalence China now reports 18.6% adult obesity prevalence up from 7.1% in 2000 combined with expanding private health insurance and regulatory approvals

By Distribution Channel: Hospital Pharmacies Retain Majority Share as Online Platforms Scale Hospital pharmacies dispensed 65.36% of 2025 volumes due to initiation during inpatient cardiometabolic events

doi: 10.1126/scitranslmed.aar7047 9 OvergaardRNavarriaAHertzCIngwersenS

Even though more people in these communities have diabetes, accessing health care is a serious challenge due to high costs, insurance coverage gaps and geographic disparities, particularly in rural and diverse communities